Stimvia’s URIS device uses electrodes placed near the peroneal nerve in the lower leg to modulate electrical activity that stimulates specific nerve pathways in the brain.
It functions as a noninvasive alternative for DBS to modulate the activity of specific brain nerve pathways. A built-in monitoring system lets doctors monitor the brain’s response to the stimuli, adjusting the neurostimulation as needed.
Its a really impressive development!!
Another FAROOQII FIND !!! 👍😀👍 This looks interesting.
Thank you for sharing, it seems more similar to Pemf than CUE1. In an case, it's still a question of electrical transcutaneous nerve modulation. Dottor Peter Tass set a precedent.
I wish everything would stop being called an "add on". Why can't they try it without having people also be on meds?
Does anyone know of a way to keep an eye on when the next phase begins? I'm hoping they will include folks who have not yet begun meds.
Long-Term Satisfaction and Patient-Centered Outcomes of Deep Brain Stimulation in Parkinson’s DiseaseRelationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease March 2022
When is the right stage to have Deep Brain Stimulation?
Neurological Plasticity 
STUDY: "Physical Activity Linked to Larger Volume, Increased Health of Brain"
